Patent details

EP1037926 Title: TREATMENT WITH ANTI-ErbB2 ANTIBODIES

Basic Information

Publication number:
EP1037926
PCT Application Number:
PCT/US/1998/026266
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP989638408
PCT Publication Number:
WO/1999/031140
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT WITH ANTI-ErbB2 ANTIBODIES
French Title of Invention:
TRAITEMENT AUX ANTICORPS ANTI-ErbB2
German Title of Invention:
BEHANDLUNG MIT ANTIKÖRPERN GEGEN ERBB2
SPC Number:

Dates

Filing date:
10/12/1998
Grant date:
15/01/2014
EP Publication Date:
15/01/2014
PCT Publication Date:
24/06/1999
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/09/2000
EP B1 Publication Date:
15/01/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/12/2014
Expiration date:
10/12/2018
Renunciation date:
Revocation date:
07/02/2018
Annulment date:

Owner

From:
10/12/1998
 
 

Name:
GENENTECH, INC.
Address:
1 DNA WAY, SOUTH SAN FRANCISCO CA 94080-4990, United States (US)

Inventor

1

Name:
PATON Virginia, E.
Address:
United States (US)

2

Name:
DESMOND-HELLMANN Susan Diane of Genentech, inc.
Address:
United States (US)

3

Name:
SHAK Steven
Address:
United States (US)

Priority

Priority Number:
69346 P
Priority Date:
12/12/1997
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/00;

Publication

European Patent Bulletin

Issue number:
201921
Publication date:
22/05/2019
Description:
Revocation of the European patent
Filing date Document type Number of pages